More specifically, the immunohistochemical results show that the percentage of NUCKS positive cases in invasive breast cancer is increased in grade I (6/9, 67%), grade II (37/41, 90%) and III (6/8, 75%) carcinomas compared to normal cases. This evidence concerns the gene NUCKS1 and carcinoma.